Trial Profile
Safety of colonoscopic therapy with apixaban switched from warfarin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2018
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- 05 Sep 2018 Status changed from not yet recruiting to completed.
- 06 Nov 2015 New trial record